Literature DB >> 3661284

The effect of increased cocaine use on drug treatment.

J L Black1, M P Dolan, W E Penk, R Robinowitz, H A DeFord.   

Abstract

Trends in primary illicit drug use were monitored in an inpatient drug treatment program over a 10-year period, along with illicit drug used in a methadone maintenance program over a six-year period. The percentage of cocaine users admitted for inpatient treatment showed an increase for each six-month interval over the past three-year period. Cocaine was found to be the most frequently used illicit drug by methadone maintenance clients, and its continued use disrupted both inpatient and outpatient treatment. Implications for treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661284     DOI: 10.1016/0306-4603(87)90042-6

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  5 in total

1.  Enhancement of cocaine's abuse liability in methadone maintenance patients.

Authors:  K L Preston; J T Sullivan; E C Strain; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Behavioral factors predicting response to employment-based reinforcement of cocaine abstinence in methadone patients.

Authors:  August F Holtyn; Wendy Donlin Washington; Todd W Knealing; Conrad J Wong; Ken Kolodner; Kenneth Silverman
Journal:  Transl Issues Psychol Sci       Date:  2016-06

3.  Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

Authors:  Alison Oliveto; James Poling; Michael J Mancino; Zachary Feldman; Joseph F Cubells; Rhonda Pruzinsky; Kishorchandra Gonsai; Christopher Cargile; Mehmet Sofuoglu; Mohit P Chopra; Gerardo Gonzalez-Haddad; Kathleen M Carroll; Thomas R Kosten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

4.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

5.  ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Authors:  Catherine J Spellicy; Thomas R Kosten; Sara C Hamon; Mark J Harding; David A Nielsen
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.